Pulmonary anti-inflammatory effects of chitosan microparticles containing betamethasone

Journal of Bioactive and Compatible Polymers

Volumn 22, Issue 1, 2007, Pages 30-41

  Huang, Y C ^a   Vieira, A ^b   Yeh, M K ^c   Chiang, C H ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b SIMON FRASER UNIVERSITY   (Canada)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Betamethasone; Bronchoalveolar; Chitosan; Inflammation; Lactate dehydrogenase activity; Leukocyte infiltration; Microparticles; MPO activity; Polymorphonuclear neutrophils; Pulmonary delivery

Indexed keywords

BLOOD; CELLS; CONTROLLED DRUG DELIVERY; ENZYME KINETICS; INFILTRATION; LIVING SYSTEMS STUDIES; PULMONARY DISEASES;

BETAMETHASONE; BRONCHOALVEOLAR; CHITOSAN; INFLAMMATION; LACTATE DEHYDROGENASE; LEUKOCYTE INFILTRATION; MICROPARTICLES; POLYMORPHONUCLEAR NEUTROPHILS; PULMONARY DELIVERY;

POLYSACCHARIDES;

BETAMETHASONE; CHITOSAN; LACTATE DEHYDROGENASE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; ENZYME ACTIVITY; LUNG; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PNEUMONIA; RAT; STATISTICAL SIGNIFICANCE;

EID: 33845530579     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911506073639     Document Type: Article

References (28)

1. Okamoto, H., Aoki, M. and Danjo, K. (2000). A Novel Apparatus for Rat In Vivo Evaluation of Dry Powder Formulations for Pulmonary Administration, J. Pharm. Sci., 89: 1028-1035.
2. Dokka, S., Toledo, D., Shi, X., Castranova, V. and Rojanasakul, Y. (2000). Oxygen Radical-mediated Pulmonary Toxicity Induced by some Cationic Liposome, Pharm. Res., 17: 521-525.
3. Courrier, H. M., Butz, N. and Vandamme, T. F. (2002). Pulmonary Drug Delivery Systems: Recent Developments and Prospects, Crit. Rev. Ther. Drug Carrier Sys., 19: 425-498.
4. Cefalu, W. T., Rosenstock, J. and Bindra, S. (2002). Inhaled Insulin: A Novel Route for Insulin Delivery, Expert Opin. Investig. Drugs, 11: 687-691.
5. Sakagami, M., Sakon, K., Kinoshita, W. and Makino, Y. (2001). Enhanced Pulmonary Absorption Following Aerosol Administration of Mucoadhesive Powder Microspheres, J. Control. Rel., 77: 117-129.
6. Aspden, T. J., Illum, L. and Skaugrud, O. (1995). The Absence of Chitosan Toxicity when Applied to Nasal Mucosa, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22: 550-556.
7. Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S. and Illum, L. (1999). Evaluation of the Clearance Characteristics of Bioadhesive Systems in Humans, Int. J. Pharm., 178: 55-65.
8. van der Lubben, I. M., Verhoef, J. C., Borchard, G. and Junginger, H. E. (2001). Chitosan for Mucosal Vaccination, Adv. Drug Del. Rev., 52: 139-144.
9. Singla, A. K. and Chawla, M. (2001). Chitosan: Some Pharmaceutical and Biological Aspects-An Update, J. Pharm. Pharmacol., 53: 1047-1067.
10. Aksungur, P., Sungur, A., Unal, S., Iskit, A. B., Squier, C. A. and Senel, S. (2004). Chitosan Delivery Systems for the Treatment of Oral Mucositis: In Vitro and In Vivo Studies, J. Control. Rel., 98: 269-279.
11. Akbuga, J., Ozbas-Turan, S. and Erdogan, N. (2004). Plasmid-DNA Loaded Chitosan Microspheres for In Vitro IL-2 Expression, Eur. J. Pharm. Biopharm., 58: 501-507.
12. Dastan, T. and Turan, K. (2004). In Vitro Characterization and Delivery of Chitosan-DNA Microparticles into Mammalian Cells, J. Pharm. Sci., 7: 205-214.
13. Hashish, A. H., Bailey, A. G. and Williams, T. J. (1994). Modeling the Effect of Charge on Selective Deposition of Particles in a Diseased Lung Using Aerosol Boli, Phys. Med. Biol., 39: 2247-2262.
14. Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N. and Langer, R. (1997). Large Porous Particles for Pulmonary Drug Delivery, Science, 276: 1868-1871.
15. Edwards, D. A., Ben-Jebria, A. and Langer, R. (1998). Recent Advances in Pulmonary Drug Delivery using Large, Porous Inhaled Particles, J. Appl. Physiol., 85: 379-385.
16. Vanbever, R., Mintzes, J. D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R. and Edwards, D. A. (1999). Formulation and Physical Characterization of Large Porous Particles for Inhalation, Pharm. Res., 16: 1735-1742.
17. Ben-Jebria, A., Chen, D., Eskew, M. L., Vanbever, R., Langer, R. and Edwards, D. A. (1999). Large Porous Particles for Sustained Protection from Carbachol-induced Bronchoconstriction in Guinea Pigs, Pharm. Res., 16: 555-561.
18. Huang, Y., Yeh, M. and Chiang, C. (2002). Formulation Factors in Preparing BTM-chitosan Microspheres by Spray Drying Method, Int. J. Pharm., 242: 239-342.
19. Huang, Y. C., Yeh, M. K., Cheng, S. N. and Chiang, C. H. (2003). The Characteristics of Betamethasone-loaded Chitosan Microparticles by Spray-drying Method, J. Microencapsul., 20: 459-472.
20. Asti, C., Ruggieri, V., Porzio, S., Chiusaroli, R., Melillo, G. and Caselli, G. F. (2000). Lipopolysaccharide-induced Lung Injury in Mice. I. Concomitant Evaluation of Inflammatory Cells and Haemorrhagic Lung Damage, Pulm. Pharmacol. Ther., 13: 61-69.
21. Xu, H., Vanhooren, H. M., Verbeken, E., Yu, L., Lin, Y., Nemery, B. and Hoet, P. H. (2004). Pulmonary Toxicity of Polyvinyl Chloride Particles after Repeated Intratracheal Instillations in Rats. Elevated CD4/CD8 Lymphocyte Ratio in Bronchoalveolar Lavage, Toxicol. Appl. Pharmacol., 194: 122-131.
22. Huang, Y. C., Vieira, A., Huang, K. L., Yeh, M. K. and Chiang, C. H. (2005). Pulmonary Inflammation Caused by Chitosan Microparticles, J. Biomed. Mater. Res., 75: 283-287.
23. Bivas-Benita, M., van Meijgaarden, K. E., Franken, K. L., Junginger, H. E., Borchard, G., Ottenhoff, T. H. and Geluk, A. (2004). Pulmonary Delivery of Chitosan-DNA Nanoparticles Enhances the Immunogenicity of a DNA Vaccine Encoding HLA-A*0201-Restricted T-cell Epitopes of Mycobacterium Tuberculosis, Vaccine, 22: 1609-1615.
24. Kumar, M., Behera, A. K., Lockey, R. F., Zhang, J., Bhullar, G., De La Cruz, C. P., Chen, L. C., Leong, K. W., Huang, S. K. and Mohapatra, S. S. (2002). Intranasal Gene Transfer by Chitosan-DNA Nanospheres Protects BALB/c Mice Against Acute Respiratory Syncytial Virus Infection, Hum. Gene Ther., 13: 415-425.
25. Roy, K., Mao, H. Q., Huang, S. K. and Leong, K. W. (1999). Oral Gene Delivery with Chitosan-DNA Nanoparticles Generates Immunologic Protection in a Murine Model of Peanut Allergy, Nat. Med., 5: 387-391.
26. Krauland, A. H., Guggi, D. and Bernkop-Schnurch, A. (2004). Oral Insulin Delivery: The Potential of Thiolated Chitosan-insulin Tablets on Non-diabetic Rats, J. Control. Rel., 95: 547-555.
27. Vila, A., Sanchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V. and Alonso, M. J. (2004). Low Molecular Weight Chitosan Nanoparticles as New Carriers for Nasal Vaccine Delivery in Mice, Eur. J. Pharm. Biopharm., 57: 123-131.
28. Agnihotri, S. A. and Aminabhavi, T. M. (2004). Controlled Release of Clozapine Through Chitosan Microparticles Prepared by a Novel Method, J. Control. Rel., 96: 245-259.